Recombinant Human GRB7 Protein: Biology & Research Applications
Recombinant Human GRB7 Protein: Biology & Research Applications
Recombinant Human GRB7 Protein is a eukaryotically expressed adaptor protein that plays a central role in receptor tyrosine kinase-mediated signal transduction, making it an essential research tool for studies in oncology, cell migration, and cancer cell proliferation.
- Protein Name
- Recombinant Human GRB7 Protein
- Also Known As
- Growth Factor Receptor-Bound Protein 7; GRB7
- Protein Family
- GRB7 adaptor protein family (includes GRB7, GRB10, GRB14)
- Key Functional Domains
- SH2 domain, PH domain, RA domain, proline-rich region
- Primary Signaling Partners
- EGFR, HER2/ErbB2, focal adhesion kinase (FAK)
- Key Research Areas
- Oncology, breast cancer, signal transduction, cell migration
- Product SKU
- rp377079
What Is GRB7? Gene, Protein, and Biological Context
GRB7 (Growth Factor Receptor-Bound Protein 7) is a multi-domain adaptor protein encoded by the GRB7 gene located on human chromosome 17q12, a region frequently amplified in breast and gastric cancers. As a member of the GRB7 family—which also includes GRB10 and GRB14—GRB7 lacks intrinsic enzymatic activity but functions as a critical scaffold that couples activated receptor tyrosine kinases (RTKs) to downstream signaling cascades.
GRB7 was originally identified as a binding partner of the epidermal growth factor receptor (EGFR) and subsequently shown to interact with multiple RTKs, including HER2/ErbB2, EphB1, RET, and focal adhesion kinase (FAK). These interactions are primarily mediated through GRB7's C-terminal SH2 (Src Homology 2) domain, which binds phosphotyrosine motifs on activated receptors. Additional structural modules—including a pleckstrin homology (PH) domain, a Ras-associating (RA) domain, and a proline-rich N-terminal region—enable GRB7 to integrate multiple upstream signals and engage diverse effector proteins.
Physiologically, GRB7 is implicated in embryonic development, cell migration, and angiogenesis. In pathological contexts, GRB7 overexpression has been documented in breast, ovarian, esophageal, and gastric cancers, often correlating with aggressive tumor phenotypes and poor clinical prognosis. Its co-amplification with HER2 on chromosome 17q12 makes it particularly relevant to HER2-positive breast cancer research.
Structural Features of GRB7 Protein
Understanding the domain architecture of GRB7 is essential for interpreting its biological functions and designing mechanistic experiments. The human GRB7 protein contains several well-characterized structural modules arranged from the N- to C-terminus:
- Proline-rich N-terminal region: Mediates interactions with SH3 domain-containing proteins, contributing to protein complex assembly and cytoskeletal regulation.
- RA (Ras-Associating) domain: Facilitates interaction with Ras GTPases, linking GRB7 to Ras-MAPK pathway modulation.
- PH (Pleckstrin Homology) domain: Enables membrane localization by binding phosphoinositides, particularly phosphatidylinositol lipids generated during PI3K activation.
- BPS (Between PH and SH2) region: A distinctive feature of the GRB7 family that contributes to receptor selectivity.
- SH2 domain: The primary phosphotyrosine-binding module responsible for high-affinity interactions with activated RTKs such as EGFR and HER2.
Recombinant Human GRB7 Protein produced for research purposes typically encompasses the full-length sequence or defined domain constructs, enabling investigators to perform binding assays, structural studies, and inhibitor screening targeting specific domains. The SH2 domain of GRB7, in particular, has attracted interest as a drug target given its role in mediating oncogenic signaling downstream of HER2.
Research Applications of Recombinant Human GRB7 Protein
Recombinant Human GRB7 Protein is a versatile reagent supporting a broad range of experimental workflows in oncology and cell biology research:
- Protein–Protein Interaction Studies: GRB7 protein is used in co-immunoprecipitation, pull-down assays, and surface plasmon resonance (SPR) experiments to map interactions with RTKs (e.g., EGFR, HER2) and other signaling effectors.
- SH2 Domain Inhibitor Screening: The recombinant protein serves as a target in high-throughput and biochemical screening campaigns aimed at identifying small molecules or peptides that disrupt GRB7-HER2 interaction, a strategy with potential therapeutic relevance in breast cancer.
- Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting: Recombinant GRB7 is employed as a positive control or standard in immunoassays to validate antibody specificity and quantify endogenous GRB7 levels in cell or tissue lysates.
- Structural Biology: Purified recombinant GRB7 domains are used for X-ray crystallography, NMR spectroscopy, and cryo-EM studies to elucidate molecular mechanisms of ligand recognition.
- Cell Migration and Invasion Assays: Researchers introduce recombinant GRB7 or use it to develop functional blocking tools for studying its role in cytoskeletal reorganization and cancer cell invasiveness.
- Biomarker Research: Given GRB7 overexpression in HER2-amplified tumors, the recombinant protein supports the development and validation of diagnostic assays and biomarker panels.
Aladdin Scientific's Recombinant Human GRB7 Protein (SKU: rp377079) is suitable for these applications, providing researchers with a reliable, characterized source of GRB7 for in vitro experimentation.
Handling, Storage, and Quality Considerations
Proper handling and storage of Recombinant Human GRB7 Protein are critical to maintaining protein integrity and experimental reproducibility. Researchers should observe the following general guidelines:
- Storage temperature: Recombinant proteins are typically stored at –70 °C or –80 °C for long-term preservation. Avoid repeated freeze–thaw cycles, which can lead to protein aggregation and loss of biological activity.
- Aliquoting: Upon receipt, it is advisable to aliquot the protein into single-use volumes to minimize freeze–thaw events.
- Reconstitution: If supplied lyophilized, reconstitute according to the manufacturer's datasheet using the recommended buffer. Allow the vial to equilibrate at room temperature before gentle mixing; do not vortex.
- Working concentration: Optimal working concentrations should be determined empirically for each assay format. Refer to the product datasheet for suggested ranges.
- Quality assessment: Confirm protein integrity by SDS-PAGE and verify identity by Western blot or mass spectrometry before use in critical experiments.
For specific formulation details, purity specifications, and recommended storage conditions for Aladdin Scientific's Recombinant Human GRB7 Protein (rp377079), consult the product datasheet available on the Aladdin Scientific website or contact technical support.
Frequently asked questions
What is GRB7 protein and why is it important in cancer research?
GRB7 (Growth Factor Receptor-Bound Protein 7) is an adaptor protein that lacks intrinsic catalytic activity but mediates signal transduction downstream of activated receptor tyrosine kinases such as EGFR and HER2. It is important in cancer research because the GRB7 gene is co-amplified with HER2 on chromosome 17q12 in several cancers, including breast and gastric cancer, where its overexpression is associated with aggressive tumor behavior and poor prognosis. Targeting GRB7—particularly its SH2 domain—is an active area of therapeutic investigation.
What experimental techniques can Recombinant Human GRB7 Protein be used for?
Recombinant Human GRB7 Protein is suitable for a variety of in vitro applications including protein–protein interaction assays (pull-down, co-IP, SPR), SH2 domain inhibitor screening, ELISA standard preparation, Western blot positive controls, and structural biology studies such as X-ray crystallography or NMR. It can also support cell migration and invasion research when used to develop functional blocking tools or as a reference in pathway analysis experiments.
How should Recombinant Human GRB7 Protein be stored to maintain its activity?
Recombinant Human GRB7 Protein should generally be stored at –70 °C to –80 °C for long-term stability. To prevent activity loss from repeated freeze–thaw cycles, aliquot the protein into small, single-use volumes upon receipt. If the protein is supplied in lyophilized form, reconstitute it gently with the recommended buffer according to the product datasheet without vortexing. Always consult the specific product datasheet for formulation-dependent storage recommendations.
What is the significance of GRB7's SH2 domain as a drug target?
The SH2 domain of GRB7 mediates its direct binding to phosphotyrosine residues on activated HER2 and other RTKs, making it an essential node in oncogenic signaling. Because GRB7 is overexpressed in many HER2-amplified tumors, blocking the GRB7 SH2–HER2 interaction offers a strategy to suppress downstream proliferative and migratory signaling independently of kinase inhibition. Researchers use recombinant GRB7 protein in biochemical screening assays to identify peptide or small-molecule inhibitors that competitively disrupt this SH2-mediated interaction.
References
- Stein D, Wu J, Bhatt S, et al. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J. 1994;13(6):1331-1340. PMID:8137819
- Pero SC, Oligino L, Daly RJ, et al. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7. J Biol Chem. 2002;277(13):11918-11926. PMID:11805106
- Chu PY, Huang LY, Hsu CH, et al. Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis. J Biol Chem. 2009;284(30):20215-20226. PMID:19478083
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)